| ORIGINAL ARTICLE |
|
| Year : 2023 | Volume
: 11
| Issue : 1 | Page : 19-23 |
|
|
A randomized controlled comparative study of functional outcome of chronic refractory plantar fasciitis treated with platelet-rich plasma injection and corticosteroid injection
Ashwanth Narayan Balashanmugam, Prem Kumar Kothimbakkam, V Bharath, RK Guhan, A Ganesh, M Vijayashankar
Department of Orthopaedics, Chettinad Hospital and Research Institute, Chennai, Tamil Nadu, India
Correspondence Address:
Prof. Dr. M Vijayashankar
Department of Orthopaedics, Chettinad Hospital and Research Institute, Kelambakkam, Chennai 600126, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JOASP.JOASP_25_22
|
|
|
BACKGROUND: Chronic refractory plantar fasciitis is one of the common causes for long-standing pain in the heel region, which has to be intervened with minimally invasive intralesional injections. The aim of this randomized controlled study was done to compare the functional outcome of patients who have not responded to 6 weeks of conservative treatment for chronic plantar fasciitis (6 months), treated with platelet-rich plasma (PRP) injection and corticosteroid injection. PATIENTS AND METHODS: All patients diagnosed with chronic plantar fasciitis, who did not respond to 6 weeks of conservative trial who came to the orthopedic department of this institute from September 2019 to March 2021, were added in this research. Thirty patients in each group were randomly assigned as per inclusion and exclusion criteria. RESULTS: The mean age receiving PRP (group 1) was 42 and corticosteroid (group 2) was 39.87, respectively. This study comprising of 60 patients had 13 males and 47 females, respectively. Among them, 7 males and 23 females received PRP injection and 6 males and 24 females received corticosteroid injection. At the conclusion of 6 months, the PRP group had a sustained surge in foot and ankle outcome score (FAOS) score (87.23), on the other hand, the corticosteroid group (77.5) had a fall in the FAOS score after three months. At the completion of 6 months, the PRP group had a decrease in visual anolog score (VAS) score (1.93), and the corticosteroid group (3.33) had a raise in the VAS score after 3 months. CONCLUSION: Our research has concluded that PRP injection is efficacious in a long run. At the same time, corticosteroid injection efficacy started to decline after three months. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
